Preclinical efficacy of ANPD-001 supports further development for Parkinson’s disease
July 10, 2023
The loss of the dopaminergic neurons in the substantia nigra and their projections in the putamen cause motor disabilities, which are one of the main hallmarks in patients with Parkinson’s disease (PD).